Journals / Bezmiâlem Science / 2020 / Cilt: 8 - Sayı: 3

Vaccination Studies Against COVID-19 Agent: Current Status

COVİD-19 Etkenine Karşı Aşı Çalışmaları: Mevcut Durum

Pages
90–97
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The purpose of this review is to contribute to the analysis of vaccine development strategies, vaccine development stages, phase studies and the difficulties, production stages and current status of potential vaccine studies developed to prevent COVID-19.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The emergence of the new pathogenic viral strains is a constant threat to global health.
📊
Key Findings & Data:The latest new coronavirus strain coronavirus-2019 (COVID-19) is the best-known example of this.
💡
Conclusion & Impact:The purpose of this review is to contribute to the analysis of vaccine development strategies, vaccine development stages, phase studies and the difficulties, production stages and current status of potential vaccine studies developed to prevent COVID-19.
🔬Design:Review & Systematic Survey
📍Scope:2019 Verileri
⚙️Variables:Domain Parameters

Abstract

The emergence of the new pathogenic viral strains is a constant threat to global health. The latest new coronavirus strain coronavirus-2019 (COVID-19) is the best-known example of this. COVID-19, caused by the severe acute respiratory syndrome-CoV-2 virus has quickly spread around the globe. The applications of drug and vaccine practices, and the identification of potential candidates are of high importance against this pandemic. On healthy adults, a proper evaluation of potential vaccines in parallel with vaccination studies on animal models and an enlargement of production capacity will benefit minimum risk and accelerated COVID-19 vaccine studies for human subjects. The purpose of this review is to contribute to the analysis of vaccine development strategies, vaccine development stages, phase studies and the difficulties, production stages and current status of potential vaccine studies developed to prevent COVID-19.

Özet

Yeni patojenik viral suşların ortaya çıkması küresel sağlık için sürekli bir tehdit oluşturmaktadır. En son yeni koronavirüs-2019 (COVİD-19), bunun en iyi bilinen örneğidir. Şiddetli akut solunum yolu enfeksiyonu-koronavirüs-19 virüsünün neden olduğu COVİD-19 hızla dünyaya yayılmıştır. Bu salgına karşı ilaç ve aşı çalışmalarının gerçekleştirilmesi ve potansiyel aşı adaylarının hızlı bir şekilde tanımlanması oldukça önemlidir. Sağlıklı yetişkinlerde aday aşıların, hayvan modellerindeki aşı çalışmalarına paralel olarak doğru şekilde değerlendirilmesi ve üretim kapasitesinin büyütülmesi, insan denekler için minimum risk ve hızlandırılmış COVİD-19 aşı çalışmalarına fayda sağlayacaktır. Bu derlemenin amacı, aşı geliştirme stratejileri, aşı gelişim aşamaları, faz çalışmaları ile COVİD-19’u önlemeye yönelik geliştirilen aday aşı çalışmalarının güçlükleri, üretim aşamaları ve mevcut durumları hakkında bilgi vererek analiz edilebilmelerine katkı sunmaktır.

🔖

Cite This Article

HİNTİSTAN, S., KAZAK, A. (2022). Vaccination Studies Against COVID-19 Agent: Current Status. Bezmiâlem Science, Cilt: 8 - Sayı: 3, 90–97. https://ajindex.com/articles/464012

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Tse LV, Meganck RM, Graham RL, Baric RS. The Current and Future State of Vaccines, Antivirals and Gene Therapies Against Emerging Coronaviruses. Front Microbiol 2020;11:658
  2. World Health Organization Press Conference 2020 The World Health Organization (WHO) Has Officially Named the Disease Caused by the Novel Coronavirus as COVID-19. Last Accessed Date:12.05.2020. Available from: https://www.who.int/docs/defaultsource/coronaviruse/situation-reports/20200312-sitrep-52-covid-19. pdf?sfvrsn=e2bfc9c0_4
  3. Cascella M, Rajnik M, Cuomo A, Dulebohn S, Napolli R. Features, Evaluation and Treatment Coronavirus (COVID-19); Stat Pearls Publishing: Treasure Island, FL, USA: 2020
  4. Fehr AR, Perlman S. Coronaviruses: An Overview of Their Replication and Pathogenesis. Methods in Molecular Biology (Clifton, N.J.) 2015;1282:1-23
  5. Raj VS, Osterhaus AD, Fouchier RA, Haagmans BL. MERS: Emergence of a Novel Human Coronavirus. Curr Opin Virol 2014;5:58-62
  6. Jin Y, Yang H, Ji W, Wu W, Chen S, Zhang W, Duan G. Virology, Epidemiology, Pathogenesis, and Control of COVID-19. Viruses 2020;12:372
  7. Li H, Liu SM, Yu XH, et al. Coronavirus Disease 2019 (COVID-19): Current Status and Future Perspective. Int J Antimicrob Agents 2020;55:105951
  8. Baig AM, Khaleeq A, Ali U, Syeda H. Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host-Virus Interaction, and Proposed Neurotropic Mechanisms. ACS Chemical Neuroscience 2020;11:995-8
  9. Tisoncik JR, Korth MJ, Simmons CP, Farrar J, Martin TR, Katze MG. Into the eye of the cytokine storm. Microbiol Mol Biol Rev 2012;76:16-32
  10. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet 2020;395:507-13
  11. Zhou JH, Wang YN, Chang QY, Ma P, Hu Y, Cao X. Type III Interferons in Viral Infection and Antiviral Immunity. Cell Physiol Biochem 2018;51:173-85
  12. Rouse BT, Lukacher AE. Some unmet challenges in the immunology of viral infections. Discovery Med 2010;10:363-70
  13. Zimmermann P, Curtis N. Factors That Influence the Immune Response to Vaccination. Clin Microbiol Rev 2019;32:e00084-18
  14. Broadbent AJ, Boonnak K, Subbarao K. Respiratory Virus Vaccine. Mucosal Immunology 2015:1129-70
  15. Gül B, Dikmen BY. Aşı Adjuvanları ve İstenmeyen Etkileri. Veteriner Farmakoloji ve Toksikoloji Derneği Bülteni 2019;10:91-105
  16. Graham BS. Rapid COVID-19 Vaccine Development. Science 20